DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Clazosentan is an investigational drug.
There have been 8 clinical trials for Clazosentan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2007.
The most common disease conditions in clinical trials are Subarachnoid Hemorrhage, Hemorrhage, and Vasospasm, Intracranial. The leading clinical trial sponsors are Actelion, Idorsia Pharmaceuticals Ltd., and St. Michael's Hospital, Toronto.
Recent Clinical Trials for Clazosentan
|Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain||Idorsia Pharmaceuticals Ltd.||Phase 3|
|A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function||Idorsia Pharmaceuticals Ltd.||Phase 1|
|A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan||Idorsia Pharmaceuticals Ltd.||Phase 1|